Medicine & Life Sciences
Prostatic Neoplasms
100%
Cytotoxic T-Lymphocytes
58%
Cancer Vaccines
43%
Subunit Vaccines
43%
Neoplasms
40%
Helper-Inducer T-Lymphocytes
37%
TARP
33%
Clinical Studies
24%
Therapeutics
20%
Neoplasm Antigens
19%
Androgens
16%
Prostate
15%
Melanoma
14%
Therapeutic Uses
14%
Vaccination
14%
Immune System
14%
Homeostasis
13%
Animal Models
13%
Lymphocytes
12%
Peptides
11%
Antigens
11%
T-Lymphocytes
11%
Safety
10%
Animals
9%
Proteins
6%
Agriculture & Biology
prostatic neoplasms
86%
androgens
18%
estrogens
17%
genetic polymorphism
13%
mutagens
13%
etiology
13%
risk factors
12%
enzyme polymorphism
9%
case-control studies
8%
disease prevention
7%
protein products
7%
synthesis
6%
gonadotropins
6%
biopsy
6%
enzymes
5%
image analysis
5%